Article Versions Notes

Krishnan S, Srivastava PK, Attaluri J, Nayeri R, Chatterjee D, Patel J, Nsair A, Budoff M, Nayeri A. Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence. Journal of Cardiovascular Development and Disease. 2025; 12(1):19. https://doi.org/10.3390/jcdd12010019

Krishnan, Srikanth, Pratyaksh K. Srivastava, Jayram Attaluri, Rebecca Nayeri, Dhananjay Chatterjee, Jay Patel, Ali Nsair, Matthew Budoff, and Arash Nayeri. 2025. "Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence" Journal of Cardiovascular Development and Disease 12, no. 1: 19. https://doi.org/10.3390/jcdd12010019

Krishnan, S., Srivastava, P. K., Attaluri, J., Nayeri, R., Chatterjee, D., Patel, J., Nsair, A., Budoff, M., & Nayeri, A. (2025). Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence. Journal of Cardiovascular Development and Disease, 12(1), 19. https://doi.org/10.3390/jcdd12010019